BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 28402230)

  • 1. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
    Hu X; Jiang H; Jiang X
    Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
    Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
    Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
    Yi L; Ouyang L; Wang S; Li SS; Yang XM
    J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
    Wang Y; Cheng N; Luo J
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.
    Huang Y; Tan D; Xiao J; Li Q; Zhang X; Luo Z
    J Cancer Res Ther; 2018 Jan; 14(1):111-118. PubMed ID: 29516971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF4A3-induced circFIP1L1 represses miR-1253 and promotes radiosensitivity of nasopharyngeal carcinoma.
    Zhou X; Yuan G; Wu Y; Yan S; Jiang Q; Tang S
    Cell Mol Life Sci; 2022 Jun; 79(7):357. PubMed ID: 35680727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis.
    Liu H; Chen Q; Zheng W; Zhou Y; Bai Y; Pan Y; Zhang J; Shao C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
    Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
    Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated long non-coding RNA SNHG7 restricts proliferation and boosts apoptosis of nasopharyngeal carcinoma cells by elevating microRNA-140-5p to suppress GLI3 expression.
    Dai Y; Zhang X; Xing H; Zhang Y; Cao H; Sang J; Gao L; Wang L
    Cell Cycle; 2020 Feb; 19(4):448-463. PubMed ID: 31944163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
    Han YY; Liu K; Xie J; Li F; Wang Y; Yan B
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.
    Sun C; Shen C; Zhang Y; Hu C
    Adv Clin Exp Med; 2021 Jan; 30(1):55-65. PubMed ID: 33529508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Wang M; Liu G; Shan GP; Wang BB
    Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.